CORCEPT THERAPEUTICS INC
Public company- Headquarters
- REDWOOD CITY, California
- Ticker
- CORT
- CIK
- 0001088856
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| President of Corcept EndocrinologySean Maduck | Sep 23, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- ACADIA PHARMACEUTICALS INC
Executive Vice President, Head of Research and Development departs: Elizabeth H.Z. Thompson, Ph.D.
- KYNTRA BIO, INC.
Class III director appointed: Andrew E. Singer, MBA
- BIOMARIN PHARMACEUTICAL INC
WARN notice: Novato, CA
- Oruka Therapeutics, Inc.
Chief Commercial Officer appointed: Todd Edwards
- Executive departure
President of Corcept Endocrinology departs: Sean Maduck
Sean Maduck, President of Corcept Endocrinology of CORCEPT THERAPEUTICS INC, resigns the role, effective October 1, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 23, 2026Role: President of Corcept Endocrinology
Only one public record so far. We add events as soon as a new filing lands; watch CORCEPT THERAPEUTICS INC to get them in your digest.
Last verified Nov 8, 2026